Central African Republic vs Guatemala: Access to anti-retroviral drugs, female
Central African Republic
73.0%
in 2024
Guatemala
73.0%
in 2024
Central African Republic rank
71st
Guatemala rank
71st
Access to anti-retroviral drugs, female over time
- Central African Republic
- Guatemala
How they compare
Central African Republic currently reports 73.0% against 73.0% in Guatemala, a difference of 0.0%.
Across all 25 years both countries report, Guatemala has been ahead every year.
Central African Republic ranks 71st and Guatemala ranks 71st of 141 countries.
Guatemala has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central African Republic | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.4% | 10.3% | 7.9% | Guatemala |
| 2010s | 26.1% | 60.2% | 34.1% | Guatemala |
| 2020s | 65.6% | 72.4% | 6.8% | Guatemala |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Central African Republic or Guatemala?
- Central African Republic, at 73.0% against 73.0% in Guatemala as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Central African Republic and Guatemala?
- 0.0%, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Guatemala?
- 25 years are reported by both, from 2000 to 2024.
- How do Central African Republic and Guatemala rank globally for access to anti-retroviral drugs, female?
- Central African Republic ranks 71st and Guatemala ranks 71st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.